Novartis AG (NYSE:NVS) will be issuing its quarterly earnings data before the market opens on Tuesday, October 24th. Analysts expect the company to announce earnings of $1.25 per share for the quarter.

Novartis AG (NYSE NVS) traded up 0.65% during midday trading on Monday, hitting $86.30. 2,155,808 shares of the stock traded hands. Novartis AG has a one year low of $66.93 and a one year high of $86.90. The company has a market cap of $202.19 billion, a PE ratio of 31.51 and a beta of 0.73. The company’s 50-day moving average is $85.60 and its 200-day moving average is $82.21.

WARNING: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at

NVS has been the subject of a number of recent analyst reports. J P Morgan Chase & Co reaffirmed a “neutral” rating on shares of Novartis AG in a report on Tuesday, September 26th. Zacks Investment Research lowered shares of Novartis AG from a “buy” rating to a “hold” rating in a report on Thursday, September 21st. BidaskClub raised shares of Novartis AG from a “sell” rating to a “hold” rating in a report on Saturday, August 5th. Morgan Stanley raised shares of Novartis AG from an “underweight” rating to an “overweight” rating in a report on Wednesday, July 26th. Finally, Cowen and Company set a $90.00 price target on shares of Novartis AG and gave the company a “hold” rating in a report on Wednesday, August 9th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $84.13.

Novartis AG Company Profile

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.

Earnings History for Novartis AG (NYSE:NVS)

Receive News & Ratings for Novartis AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis AG and related companies with Analyst Ratings Network's FREE daily email newsletter.